0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about SaveRxCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Anguilla
  • Argentina
  • Armenia
  • Austria
  • Azerbaijan
  • Belgium
  • Belize
  • Brazil
  • Cayman Islands
  • China
  • Costa Rica
  • Estonia
  • Germany
  • Gibraltar
  • Grenada
  • Guadeloupe
  • Honduras
  • Hungary
  • Iceland
  • India
  • Ireland
  • Jordan
  • Liechtenstein
  • Malta
  • Mauritius
  • Netherlands
  • New Zealand
  • Nicaragua
  • Norway
  • Paraguay
  • Poland
  • Qatar
  • Saudi Arabia
  • Slovakia
  • Slovenia
  • Turkey
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Vanuatu
View All Countries

Latest news releases on Ofatumumab:

Ofatumumab - Wikipedia

Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation.

Ofatumumab - Genmab - Home

Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.

Ofatumumab Uses, Side Effects & Warnings - Drugs.com

Physician reviewed ofatumumab patient information - includes ofatumumab description, dosage and directions.

ARZERRA® (ofatumumab) | Patient Information

Discover ARZERRA® (ofatumumab), approved for 4 CLL treatment indications. Find dosing information & patient resources. See Important Safety Information & BOXED WARNING.

Ofatumumab (Arzerra) - Chemotherapy Drug Information

Ofatumumab (Arzerra) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of chronic lymphocytic leukemia (CLL)

Arzerra | European Medicines Agency

The active substance in Arzerra, ofatumumab, is a monoclonal antibody. A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise ...

Ofatumumab (Arzerra) Multiple Sclerosis | MS News Today

Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.

Arzerra - Udgået: 11-03-2019 - pro.medicin.dk ...

Ofatumumab er rettet mod det transmembrane differentieringsantigen CD20, som findes på normale og maligne B-celler. Binding af antistoffet til CD20 medfører ...

Genmab - Home

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Genmab kan score ny milliardjackpot - FINANS

Den schweiziske gigant Novartis overtog for et par år siden rettighederne til Genmabs ofatumumab i en handel, der potentielt kan passere langt over 1 mia. dollars.

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2019 SaveRxCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK